| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |